Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Mouldy Sioud
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Concepts & Ideas
Anatomy
Genes & Molecular Sequences
Disorders
Phenomena
Living Beings
Physiology
Sign-in to see full Profile
Network (preview)
19
Førre, Oystein
14
Leirdal, Marianne
14
Natvig, Jacob
9
Kjeldsen-Kragh, J
6
Sørensen, Dag
6
Furset, Gro
6
Cekaite, Lina
5
Abraham, Dietmar
5
Aharinejad, Seyedhossein
5
Dybwad, Anne
5
Iversen, Per Ole
5
Shadidi, Mohsen
4
Røsok, Øystein
4
Hansen, MH
4
Fløisand, Yngvar
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Mouldy Sioud (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Sioud M
Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines?
Scandinavian journal of immunology 2009;70(6):516-25.
-
2009: Hauge Helena; Fjelland Kristine Engelsen; Sioud Mouldy; Aasheim Hans-Christian
Evidence for the involvement of FAM110C protein in cell spreading and migration.
Cellular signalling 2009;21(12):1866-73.
-
2009: Flatekval Gro F; Sioud Mouldy
Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase.
Immunology 2009;128(1 Suppl):e837-48.
-
2009: Sioud Mouldy; Fløisand Yngvar
NOD2/CARD15 on bone marrow CD34+ hematopoietic cells mediates induction of cytokines and cell differentiation.
Journal of leukocyte biology 2009;85(6):939-46.
-
2009: Cekaite Lina; Hovig Eiving; Sioud Mouldy
Monitoring B cell response to immunoselected phage-displayed peptides by microarrays.
Methods in molecular biology (Clifton, N.J.) 2009;524():273-85.
-
2009: Aharinejad Seyedhossein; Sioud Mouldy; Lucas Trevor; Abraham Dietmar
Targeting stromal-cancer cell interactions with siRNAs.
Methods in molecular biology (Clifton, N.J.) 2009;487():243-66.
-
2009: Sioud Mouldy
Targeted delivery of antisense oligonucleotides and siRNAs into mammalian cells.
Methods in molecular biology (Clifton, N.J.) 2009;487():61-82.
-
2009: Sioud Mouldy
Deciphering the code of innate immunity recognition of siRNAs.
Methods in molecular biology (Clifton, N.J.) 2009;487():41-59.
-
2008: Furset Gro; Fløisand Yngvar; Sioud Mouldy
Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands.
Immunology 2008;123(2):263-71.
-
2008: Shadidi Mohsen; Sørensen Dag; Dybwad Anne; Furset Gro; Sioud Mouldy
Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma.
International journal of oncology 2008;32(1):241-7.
-
2008: Abraham Dietmar; Zins Karin; Sioud Mouldy; Lucas Trevor; Aharinejad Seyedhossein
Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts.
Frontiers in bioscience : a journal and virtual library 2008;13():5571-9.
-
2008: Sioud Mouldy
Does the understanding of immune activation by RNA predict the design of safe siRNAs?
Frontiers in bioscience : a journal and virtual library 2008;13():4379-92.
-
2008: Walchli Sebastien; Sioud Mouldy
Vector-based delivery of siRNAs: in vitro and in vivo challenges.
Frontiers in bioscience : a journal and virtual library 2008;13():3488-93.
-
2008: Sioud Mouldy; Cekaite Lina
Expression profiling of microRNAs in cancer cells: technical considerations.
Methods in molecular biology (Clifton, N.J.) 2008;439():179-90.
-
2007: Sioud Mouldy; Fløisand Yngvar
TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response.
European journal of immunology 2007;37(10):2834-46.
-
2007: Sioud Mouldy; Furset Gro; Cekaite Lina
Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs.
Biochemical and biophysical research communications 2007;361(1):122-6.
-
2007: Sioud Mouldy
RNA interference and innate immunity.
Advanced drug delivery reviews 2007;59(2-3):153-63.
-
2007: Zins Karin; Abraham Dietmar; Sioud Mouldy; Aharinejad Seyedhossein
Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
Cancer research 2007;67(3):1038-45.
-
2007: Furset Gro; Sioud Mouldy
Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule.
Biochemical and biophysical research communications 2007;352(3):642-9.
-
2007: Cekaite Lina; Furset Gro; Hovig Eivind; Sioud Mouldy
Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects.
Journal of molecular biology 2007;365(1):90-108.
-
2007: Cekaite Lina; Hovig Eivind; Sioud Mouldy
Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses.
Methods in molecular biology (Clifton, N.J.) 2007;360():335-48.
-
2007: Sioud Mouldy
An overview of the immune system and technical advances in tumor antigen discovery and validation.
Methods in molecular biology (Clifton, N.J.) 2007;360():277-318.
-
2007: Røsok Øystein; Sioud Mouldy
Discovery of differentially expressed genes: technical considerations.
Methods in molecular biology (Clifton, N.J.) 2007;360():115-29.
-
2007: Sioud Mouldy
Main approaches to target discovery and validation.
Methods in molecular biology (Clifton, N.J.) 2007;360():1-12.
-
2007: Sioud Mouldy; Melien Oyvind
Treatment options and individualized medicine.
Methods in molecular biology (Clifton, N.J.) 2007;361():327-40.
-
2007: Aharinejad Seyedhossein; Sioud Mouldy; Lucas Trevor; Abraham Dietmar
Target validation using RNA interference in solid tumors.
Methods in molecular biology (Clifton, N.J.) 2007;361():227-38.
-
2007: Sioud Mouldy; Leirdal Marianne
Druggable signaling proteins.
Methods in molecular biology (Clifton, N.J.) 2007;361():1-24.
-
2006: Sioud Mouldy; Fløisand Yngvar; Forfang Lise; Lund-Johansen Fridtjof
Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage.
Journal of molecular biology 2006;364(5):945-54.
-
2006: Huynh Trang; Wälchli Sébastien; Sioud Mouldy
Transcriptional targeting of small interfering RNAs into cancer cells.
Biochemical and biophysical research communications 2006;350(4):854-9.
-
2006: Sioud Mouldy
RNA interference below the immune radar.
Nature biotechnology 2006;24(5):521-2.
-
2006: Sioud Mouldy
Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2'-hydroxyl uridines in immune responses.
European journal of immunology 2006;36(5):1222-30.
-
2006: Sioud Mouldy
Innate sensing of self and non-self RNAs by Toll-like receptors.
Trends in molecular medicine 2006;12(4):167-76.
-
2006: Angell-Petersen Even; Spetalen Signe; Madsen Steen J; Sun Chung-Ho; Peng Qian; Carper Stephen W; Sioud Mouldy; Hirschberg Henry
Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model.
Journal of neurosurgery 2006;104(1):109-17.
-
2006: Sioud Mouldy; Haoudi Abdelali
RNA interference.
Journal of biomedicine & biotechnology 2006;2006(4):89018.
-
2006: Sioud Mouldy; Furset Gro
Molecular Basis for the Immunostimulatory Potency of Small Interfering RNAs.
Journal of biomedicine & biotechnology 2006;2006(4):23429.
-
2006: Sioud M
Ribozymes and siRnas: from structure to preclinical applications.
Handbook of experimental pharmacology 2006;(173):223-42.
-
2005: Sioud Mouldy; Iversen Per Ole
Ribozymes, DNAzymes and small interfering RNAs as therapeutics.
Current drug targets 2005;6(6):647-53.
-
2005: Sioud Mouldy
On the delivery of small interfering RNAs into mammalian cells.
Expert opinion on drug delivery 2005;2(4):639-51.
-
2005: Sioud Mouldy
Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization.
Journal of molecular biology 2005;348(5):1079-90.
-
2005: Røsok Oystein; Sioud Mouldy
Systematic search for natural antisense transcripts in eukaryotes (review).
International journal of molecular medicine 2005;15(2):197-203.
-
2005: Patzke Sebastian; Hauge Helena; Sioud Mouldy; Finne Eivind Farmen; Sivertsen Einar Andreas; Delabie Jan; Stokke Trond; Aasheim Hans-Christian
Identification of a novel centrosome/microtubule-associated coiled-coil protein involved in cell-cycle progression and spindle organization.
Oncogene 2005;24(7):1159-73.
-
2005: Sioud Mouldy; Røsok Øystein
High-throughput analysis of microRNA gene expression using sensitive probes.
Methods in molecular biology (Clifton, N.J.) 2005;309():311-20.
-
2005: Sioud Mouldy
siRNA delivery in vivo.
Methods in molecular biology (Clifton, N.J.) 2005;309():237-49.
-
2005: Sioud Mouldy; Wälchli Sébastien
Strategies for the design of random siRNA libraries and the selection of anti-GFP siRNAs.
Methods in molecular biology (Clifton, N.J.) 2005;309():83-91.
-
2004: Sioud Mouldy; Røsok Oystein
Profiling microRNA expression using sensitive cDNA probes and filter arrays.
BioTechniques 2004;37(4):574-6, 578-80.
-
2004: Cekaite Lina; Haug Ola; Myklebost Ola; Aldrin Magne; Østenstad Bjørn; Holden Marit; Frigessi Arnoldo; Hovig Eivind; Sioud Mouldy
Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method.
Proteomics 2004;4(9):2572-82.
-
2004: Aharinejad Seyedhossein; Paulus Patrick; Sioud Mouldy; Hofmann Michael; Zins Karin; Schäfer Romana; Stanley E Richard; Abraham Dietmar
Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
Cancer research 2004;64(15):5378-84.
-
2004: Leirdal Marianne; Shadidy Mohsen; Røsok Øystein; Sioud Mouldy
Identification of genes differentially expressed in breast cancer cell line SKBR3: potential identification of new prognostic biomarkers.
International journal of molecular medicine 2004;14(2):217-22.
-
2004: Sioud Mouldy
Therapeutic siRNAs.
Trends in pharmacological sciences 2004;25(1):22-8.
-
2004: Røsok Øystein; Sioud Mouldy
Systematic identification of sense-antisense transcripts in mammalian cells.
Nature biotechnology 2004;22(1):104-8.
-
2004: Shadidi Mohsen; Sioud Mouldy
Selection of peptides for specific delivery of oligonucleotides into cancer cells.
Methods in molecular biology (Clifton, N.J.) 2004;252():569-80.
-
2004: Sioud Mouldy; Sørensen Dag R
Systemic delivery of synthetic siRNAs.
Methods in molecular biology (Clifton, N.J.) 2004;252():515-22.
-
2004: Leirdal Marianne; Sioud Mouldy
Gene-array analysis of glioma cells after treatment with an anti-PKCalpha siRNA: a general protocol.
Methods in molecular biology (Clifton, N.J.) 2004;252():493-500.
-
2004: Sioud Mouldy; Leirdal Marianne
Potential design rules and enzymatic synthesis of siRNAs.
Methods in molecular biology (Clifton, N.J.) 2004;252():457-69.
-
2004: Iversen Per Ole; Sioud Mouldy
Inhibition of gene expression by nucleic acid enzymes in rodent models of human disease.
Methods in molecular biology (Clifton, N.J.) 2004;252():451-6.
-
2004: Sioud Mouldy
Ribozyme- and siRNA-mediated mRNA degradation: a general introduction.
Methods in molecular biology (Clifton, N.J.) 2004;252():1-8.
-
2003: Shadidi Mohsen; Sioud Mouldy
Selective targeting of cancer cells using synthetic peptides.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2003;6(6):363-71.
-
2003: Sioud Mouldy; Sørensen Dag R
Cationic liposome-mediated delivery of siRNAs in adult mice.
Biochemical and biophysical research communications 2003;312(4):1220-5.
-
2003: Dybwad A; Lambin P; Sioud M; Zouali M
Probing the specificity of human myeloma proteins with a random peptide phage library.
Scandinavian journal of immunology 2003;57(6):583-90.
-
2003: Sørensen Dag R; Leirdal Marianne; Sioud Mouldy
Gene silencing by systemic delivery of synthetic siRNAs in adult mice.
Journal of molecular biology 2003;327(4):761-6.
-
2003: Shadidi Mohsen; Sioud Mouldy
Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(2):256-8.
-
2003: Sioud Mouldy; Sørensen Dag
Generation of an effective anti-tumor immunity after immunization with xenogeneic antigens.
European journal of immunology 2003;33(1):38-45.
-
2002: Sorensen Dag R; Leirdal Marianne; Iversen Per Ole; Sioud Mouldy
Combination of endostatin and a protein kinase Calpha DNA enzyme improves the survival of rats with malignant glioma.
Neoplasia (New York, N.Y.) 2002;4(6):474-9.
-
2002: Leirdal Marianne; Sioud Mouldy
Gene silencing in mammalian cells by preformed small RNA duplexes.
Biochemical and biophysical research communications 2002;295(3):744-8.
-
2002: Iversen Per Ole; Emanuel Peter D; Sioud Mouldy
Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth.
Blood 2002;99(11):4147-53.
-
2002: Sioud Mouldy
How does autoimmunity cause tumor regression? A potential mechanism involving cross-reaction through epitope mimicry.
Molecular medicine (Cambridge, Mass.) 2002;8(3):115-9.
-
2002: Leirdal Marianne; Sioud Mouldy
[Tyrosine kinase receptor-ras-ERK signal transduction pathway as therapeutic tarfet in cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2002;122(2):178-82.
-
2001: Hansen M H; Ostenstad B; Sioud M
Identification of immunogenic antigens using a phage-displayed cDNA library from an invasive ductal breast carcinoma tumour.
International journal of oncology 2001;19(6):1303-9.
-
2001: Sioud M
Nucleic acid enzymes as a novel generation of anti-gene agents.
Current molecular medicine 2001;1(5):575-88.
-
2001: Hansen M H; Ostenstad B; Sioud M
Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients.
Molecular medicine (Cambridge, Mass.) 2001;7(4):230-9.
-
2001: Sioud M; Hansen M H
Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries.
European journal of immunology 2001;31(3):716-25.
-
2001: Shadidi M; Sioud M
An anti-leukemic single chain Fv antibody selected from a synthetic human phage antibody library.
Biochemical and biophysical research communications 2001;280(2):548-52.
-
2001: Melien O; Christoffersen T; Sioud M
Evidence for the involvement of Gi2 in activation of extracellular signal-regulated kinases in hepatocytes.
BMC cell biology 2001;2():13.
-
2000: Sioud M; Leirdal M
Therapeutic RNA and DNA enzymes.
Biochemical pharmacology 2000;60(8):1023-6.
-
2000: Leirdal M; Sioud M
Protein kinase Calpha isoform regulates the activation of the MAP kinase ERK1/2 in human glioma cells: involvement in cell survival and gene expression.
Molecular cell biology research communications : MCBRC 2000;4(2):106-10.
-
2000: Sioud M; Hansen M; Dybwad A
Profiling the immune responses in patient sera with peptide and cDNA display libraries.
International journal of molecular medicine 2000;6(2):123-8.
-
2000: Hansen M H; Dybwad A; Førre O; Sioud M
Probing antinuclear antibody specificities by peptide phage display libraries.
Clinical and experimental rheumatology 2000;18(4):465-72.
-
2000: Sioud M; Leirdal M
Design of nuclease resistant protein kinase calpha DNA enzymes with potential therapeutic application.
Journal of molecular biology 2000;296(3):937-47.
-
2000: Myklebust J H; Smeland E B; Josefsen D; Sioud M
Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow.
Blood 2000;95(2):510-8.
-
2000: Josefsen D; Myklebust J H; Lømo J; Sioud M; Blomhoff H K; Smeland E B
Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
Stem cells (Dayton, Ohio) 2000;18(4):261-72.
-
1999: Sioud M; Leirdal M
Substitution of the 2'-hydroxyl group at position 2.1 by an amino group interferes with Mg(2+) binding and efficient cleavage by hammerhead ribozyme.
Biochemical and biophysical research communications 1999;262(2):461-6.
-
1999: Leirdal M; Sioud M
Ribozyme inhibition of the protein kinase C alpha triggers apoptosis in glioma cells.
British journal of cancer 1999;80(10):1558-64.
-
1999: Sioud M
Application of preformed hammerhead ribozymes in the gene therapy of cancer (review).
International journal of molecular medicine 1999;3(4):381-4.
-
1998: Iversen P O; Sioud M
Modulation of granulocyte-macrophage colony-stimulating factor gene expression by a tumor necrosis factor specific ribozyme in juvenile myelomonocytic leukemic cells.
Blood 1998;92(11):4263-8.
-
1998: Leirdal M; Sioud M
High cleavage activity and stability of hammerhead ribozymes with a uniform 2'-amino pyrimidine modification.
Biochemical and biophysical research communications 1998;250(1):171-4.
-
1998: Sioud M; Sørensen D R
A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth.
Nature biotechnology 1998;16(6):556-61.
-
1998: Sioud M; Mellbye O; Førre O
Analysis of the NF-kappa B p65 subunit, Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA.
Clinical and experimental rheumatology 1998;16(2):125-34.
-
1997: Sioud M; Opstad A; Hendry P; Lockett T J; Jennings P A; McCall M J
A minimised hammerhead ribozyme with activity against interleukin-2 in human cells.
Biochemical and biophysical research communications 1997;231(2):397-402.
-
1997: Sioud M
Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
Nucleic acids research 1997;25(2):333-8.
-
1997: Dybwad A; Flrre O; Sioud M
Probing for cerebrospinal fluid antibody specificities by a panel of random peptide libraries.
Autoimmunity 1997;25(2):85-9.
-
1996: Dybwad A; Førre O; Sioud M
Increased serum and synovial fluid antibodies to immunoselected peptides in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 1996;55(7):437-41.
-
1996: Sioud M
Ribozyme modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by peritoneal cells in vitro and in vivo.
European journal of immunology 1996;26(5):1026-31.
-
1996: Sioud M; Førre O; Dybwad A
Selection of ligands for polyclonal antibodies from random peptide libraries: potential identification of (auto)antigens that may trigger B and T cell responses in autoimmune diseases.
Clinical immunology and immunopathology 1996;79(2):105-14.
-
1996: Sioud M; Jespersen L
Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase.
Journal of molecular biology 1996;257(4):775-89.
-
1995: Dybwad A; Bogen B; Natvig J B; Førre O; Sioud M
Peptide phage libraries can be an efficient tool for identifying antibody ligands for polyclonal antisera.
Clinical and experimental immunology 1995;102(2):438-42.
-
1995: Ostenstad B; Dybwad A; Lea T; Førre O; Vinje O; Sioud M
Evidence for monoclonal expansion of synovial T cells bearing V alpha 2.1/V beta 5.5 gene segments and recognizing a synthetic peptide that shares homology with a number of putative autoantigens.
Immunology 1995;86(2):168-75.
-
1995: Dybwad A; Førre O; Natvig J B; Sioud M
Structural characterization of peptides that bind synovial fluid antibodies from RA patients: a novel strategy for identification of disease-related epitopes using a random peptide library.
Clinical immunology and immunopathology 1995;75(1):45-50.
-
1995: Kjeldsen-Kragh J; Rashid T; Dybwad A; Sioud M; Haugen M; Førre O; Ebringer A
Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet.
Annals of the rheumatic diseases 1995;54(3):221-4.
-
1995: Ostenstad B; Sioud M; Schlichting E; Lea T; Harboe M
Freshly isolated tumour-infiltrating T-lymphocytes have a high cytotoxic potential, as measured by their ability to induce apoptosis in the target cell.
Scandinavian journal of immunology 1995;41(1):42-8.
-
1995: Kjeldsen-Kragh J; Mellbye O J; Haugen M; Mollnes T E; Hammer H B; Sioud M; Førre O
Changes in laboratory variables in rheumatoid arthritis patients during a trial of fasting and one-year vegetarian diet.
Scandinavian journal of rheumatology 1995;24(2):85-93.
-
1994: Sioud M; Dybwad A; Jespersen L; Suleyman S; Natvig J B; Førre O
Characterization of naturally occurring autoantibodies against tumour necrosis factor-alpha (TNF-alpha): in vitro function and precise epitope mapping by phage epitope library.
Clinical and experimental immunology 1994;98(3):520-5.
-
1994: Sioud M; Opstad A; Zhao J Q; Levitz R; Benham C; Drlica K
In vivo decay kinetic parameters of hammerhead ribozymes.
Nucleic acids research 1994;22(25):5571-5.
-
1994: Suleyman S; Thompson K M; Førre O; Sioud M; Randen I; Mageed R A; Natvig J B
Three new cross-reacting idiotopes as markers for the products of two distinct human VH3 genes expressed in the early repertoire.
Scandinavian journal of immunology 1994;40(6):681-90.
-
1994: Sioud M
Interaction between tumour necrosis factor alpha ribozyme and cellular proteins. Involvement in ribozyme stability and activity.
Journal of molecular biology 1994;242(5):619-29.
-
1994: Ostenstad B; Sioud M; Lea T; Schlichting E; Harboe M
Limited heterogeneity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours.
British journal of cancer 1994;69(6):1078-82.
-
1993: Dybwad A; Førre O; Kjeldsen-Kragh J; Natvig J B; Sioud M
Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library.
European journal of immunology 1993;23(12):3189-93.
-
1993: Kjeldsen-Kragh J; Quayle A J; Skålhegg B S; Sioud M; Førre O
Selective activation of resting human gamma delta T lymphocytes by interleukin-2.
European journal of immunology 1993;23(9):2092-9.
-
1993: Suleyman S; Hosono O; Sioud M; Randen I; Thompson K M; Førre O; Natvig J B
Differentiation of human lambda I variable regions with a monoclonal antibody to a defined, germ-line-encoded idiotope correlates with V lambda Ia chemical structure.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(12):5466-75.
-
1992: Waalen K; Sioud M; Natvig J B; Førre O
Spontaneous in vivo gene transcription of interleukin-2, interleukin-3, interleukin-4, interleukin-6, interferon-gamma, interleukin-2 receptor (CD25) and proto-oncogene c-myc by rheumatoid synovial T lymphocytes.
Scandinavian journal of immunology 1992;36(6):865-73.
-
1992: Sioud M; Kjeldsen-Kragh J; Suleyman S; Vinje O; Natvig J B; Førre O
Limited heterogeneity of T cell receptor variable region gene usage in juvenile rheumatoid arthritis synovial T cells.
European journal of immunology 1992;22(9):2413-8.
-
1992: Quayle A J; Wilson K B; Li S G; Kjeldsen-Kragh J; Oftung F; Shinnick T; Sioud M; Førre O; Capra J D; Natvig J B
Peptide recognition, T cell receptor usage and HLA restriction elements of human heat-shock protein (hsp) 60 and mycobacterial 65-kDa hsp-reactive T cell clones from rheumatoid synovial fluid.
European journal of immunology 1992;22(5):1315-22.
-
1992: Sioud M; Natvig J B; Førre O
Preformed ribozyme destroys tumour necrosis factor mRNA in human cells.
Journal of molecular biology 1992;223(4):831-5.
-
1991: Sioud M; Kjeldsen-Kragh J; Quayle A J; Wiker H G; Sørskaar D; Natvig J B; Førre O
Immune responses to 18.6 and 30-kDa mycobacterial antigens in rheumatoid patients, and V beta usage by specific synovial T-cell lines and fresh T cells.
Scandinavian journal of immunology 1991;34(6):803-12.
-
1991: Sioud M; Drlica K
Prevention of human immunodeficiency virus type 1 integrase expression in Escherichia coli by a ribozyme.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(16):7303-7.
-
1991: Sioud M; Førre O; Natvig J B
T cell receptor delta diversity of freshly isolated T lymphocytes in rheumatoid synovitis.
European journal of immunology 1991;21(1):239-41.
-
1990: Pascual V; Randen I; Thompson K; Sioud M; Forre O; Natvig J; Capra J D
The complete nucleotide sequences of the heavy chain variable regions of six monospecific rheumatoid factors derived from Epstein-Barr virus-transformed B cells isolated from the synovial tissue of patients with rheumatoid arthritis. Further evidence that some autoantibodies are unmutated copies of germ line genes.
The Journal of clinical investigation 1990;86(4):1320-8.
-
1990: Sioud M; Kjeldsen-Kragh J; Quayle A; Kalvenes C; Waalen K; Førre O; Natvig J B
The V delta gene usage by freshly isolated T lymphocytes from synovial fluids in rheumatoid synovitis: a preliminary report.
Scandinavian journal of immunology 1990;31(4):415-21.
-
1989: Quayle A; Kjeldsen-Kragh J; Førre O; Waalen K; Sioud M; Kalvenes C; Natvig J B
Immunoregulatory T cell subsets and T cell activation in rheumatoid arthritis. A need for analysis on the clonal and molecular level.
Springer seminars in immunopathology 1989;11(3):273-87.
Sign-in to see more